SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-22-000130
Filing Date
2022-08-05
Accepted
2022-08-05 16:08:01
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20220630.htm   iXBRL 10-Q 1566069
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 10541
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 10557
4 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6205
  Complete submission text file 0000899923-22-000130.txt   7587576

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220630.xsd EX-101.SCH 47354
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20220630_cal.xml EX-101.CAL 80611
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20220630_def.xml EX-101.DEF 227000
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220630_lab.xml EX-101.LAB 623597
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220630_pre.xml EX-101.PRE 401982
78 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220630_htm.xml XML 1405201
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 221140841
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences